Spyre Therapeutics Inc
(NAS:SYRE)
$
86.64
-2.26 (-2.54%)
Market Cap: 7.52 Bil
Enterprise Value: 6.94 Bil
PE Ratio: 0
PB Ratio: 13.26
GF Score: 31/100 Spyre Therapeutics Inc (SYRE) Transcripts
- 1